These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22180471)

  • 1. Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group.
    Hytiroglou P; Snover DC; Alves V; Balabaud C; Bhathal PS; Bioulac-Sage P; Crawford JM; Dhillon AP; Ferrell L; Guido M; Nakanuma Y; Paradis V; Quaglia A; Theise ND; Thung SN; Tsui WM; van Leeuwen DJ
    Am J Clin Pathol; 2012 Jan; 137(1):5-9. PubMed ID: 22180471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver cirrhosis.
    Pinzani M; Rosselli M; Zuckermann M
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):281-90. PubMed ID: 21497745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reevaluation of the typing criteria for patients with chronic severe hepatitis].
    Zeng Z; Han YK; Geng H; Chen JM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):53-5. PubMed ID: 16816864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging diagnosis of cirrhosis and chronic hepatitis.
    Ito K; Mitchell DG
    Intervirology; 2004; 47(3-5):134-43. PubMed ID: 15383722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of fibrosis and cirrhosis in liver biopsies: an update.
    Germani G; Hytiroglou P; Fotiadu A; Burroughs AK; Dhillon AP
    Semin Liver Dis; 2011 Feb; 31(1):82-90. PubMed ID: 21344353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grading and staging systems for inflammation and fibrosis in chronic liver diseases.
    Goodman ZD
    J Hepatol; 2007 Oct; 47(4):598-607. PubMed ID: 17692984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.
    Garcia-Tsao G; Lim JK;
    Am J Gastroenterol; 2009 Jul; 104(7):1802-29. PubMed ID: 19455106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How to prevent complications of liver cirrhosis?].
    Adler M; Verset C; Moreno G
    Rev Med Brux; 2007 Sep; 28(4):270-5. PubMed ID: 17958020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH; Son JH; Kim TW
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis.
    Qi X; Bai M; Yang Z; Yuan S; Zhang C; Han G; Fan D
    Med Hypotheses; 2011 Apr; 76(4):522-6. PubMed ID: 21216538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond.
    Huo TI; Lee SD; Lin HC
    Liver Int; 2008 May; 28(5):606-13. PubMed ID: 18433390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes.
    Tsega E; Nordenfelt E; Hansson BG; Mengesha B; Lindberg J
    Ethiop Med J; 1992 Apr; 30(2 Suppl):1-33. PubMed ID: 1319901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B and end-stage liver disease.
    Weisberg IS; Brown RS; Sigal SH
    Clin Liver Dis; 2007 Nov; 11(4):893-916, ix. PubMed ID: 17981234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of nonalcoholic steatohepatitis.
    Liou I; Kowdley KV
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal hypertensive gastropathy: reproducibility of a classification, prevalence of elementary lesions, sensitivity and specificity in the diagnosis of cirrhosis of the liver. A NIEC multicentre study. New Italian Endoscopic Club.
    Carpinelli L; Primignani M; Preatoni P; Angeli P; Battaglia G; Beretta L; Bortoli A; Capria A; Cestari R; Cosentino F; Crotta S; Gerunda G; Lorenzini I; Maiolo P; Merighi A; Rossi A; Sangiovanni A; de Franchis R
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):533-40. PubMed ID: 9513828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cirrhosis secondary to chronic autoimmune hepatitis].
    Michel H; Blanc P
    Rev Prat; 1991 May; 41(13):1157-60. PubMed ID: 2063115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.
    Chang CH; Chau GY; Lui WY; Tsay SH; King KL; Wu CW
    Arch Surg; 2004 Mar; 139(3):320-5; discussion 326. PubMed ID: 15006892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis of cirrhosis of the liver (15-year follow-up from time of first manifestation (author's transl)].
    Ortmans H; Wildhirt E
    Dtsch Med Wochenschr; 1975 Apr; 100(15):812-4. PubMed ID: 123500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.